The Oncology Institute, Inc. TOI Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other income (expense)?
- The Oncology Institute, Inc. (TOI) reported other income (expense) of $4.02M in Q1 2026.
- How has The Oncology Institute, Inc.'s other income (expense) changed year-over-year?
- The Oncology Institute, Inc.'s other income (expense) increased by 141.6% year-over-year, from -$9.67M to $4.02M.
- What is the long-term trend for The Oncology Institute, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s other income (expense) has grown at a -7.9% compound annual growth rate (CAGR), from $34.26M to -$24.65M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.